Cassiopea Spa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The US acne treatment market size was USD 4.27 billion in 2021. The market is expected to grow from USD 4.50 billion in 2022 to USD 6.12 billion in 2029,...

Cassiopea Announces Results for First Half of 2021 Cassiopea S.p.A. / Key word(s): Half Year Results 29-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Lainate, Italy - July 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced half-year results for...

Search jobs 26-Jul-2021 Cosmo Pharmaceuticals Announces Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi® in US and Canada Cosmo Pharmaceuticals N.V. / Key word(s): Agreement/Alliance 26-Jul-2021 / 06:01 GMT/BST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland - 26 July 2021: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) announced today that Cassiopea SpA (SIX: SKIN), a company in whic...

26.06.21 07:21 Aktiennews Cassiopea Spa weist am 26.06.2021, 02:00 Uhr einen Kurs von 46.8 CHF an der Börse SIX Swiss Ex auf. Das Unternehmen wird unter "Arzneimittel" geführt. Diese Aktie haben wir in 5 Punkten analysiert und mit der Einschätzung "Buy", "Hold" bzw. "Sell" versehen. Am Ende der Analyse finden Sie die daraus resultierende Gesamtbewertung. 1. Branchenvergleich Aktienkurs: Cassiopea Spa erzielte in den vergangenen 12 Monaten eine Performance von 13,3 Prozent. Ähnliche Aktien aus der "Arzneimittel"-Branche sind im Durchschnitt um 202,09 Prozent gestiegen, was eine Underper...

Cosmo announces the start of trading of its shares on XETRA Search jobs Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous 19-Apr-2021 / 06:00 GMT/BST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Dublin, Ireland - 19 April 2021: Shares of Cosmo Pharmaceuticals NV ('Cosmo') (SIX: COPN), which have traded on the Swiss Stock Exchange since 2007, will now also trade on XETRA in Frankfurt, Germany. Trading will commence today, Monday, at 9:00am CEST under tickersymbol C43. COSMO PHARMACEUT. EO-,26 ISIN: NL0011...